Sign in

CIK 0001703647

  • Non-accelerated filer
  • Smaller reporting company

Korro Bio, Inc.

Sign in to watch
Ticker
KRRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472324450
Phone
+1 617-468-1999
Business address
60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
Former names
Frequency Therapeutics, Inc.
Open-market buys, last 90 days
$884,752
in 1 filing
Open-market sales, last 90 days
$1,763,410
in 5 filings, $1.8M under 10b5-1 plans

Net −$878,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 5 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-03-01 Lucchino David L. President and CEO Exercise or conversion · Stock Option −9,416 162,025
2021-02-08 Lucchino David L. President and CEO Exercise or conversion +16,554 $0.61 $10K 324,640
2021-02-08 Lucchino David L. President and CEO Sale −5,518 $52.50 $290K 319,122
2021-02-08 Lucchino David L. President and CEO Sale −5,518 $55.00 $303K 313,604
2021-02-08 Lucchino David L. President and CEO Sale −5,518 $57.50 $317K 308,086
2021-02-08 Lucchino David L. President and CEO Exercise or conversion · Stock Option −16,554 171,441
2021-02-03 Lucchino David L. President and CEO Exercise or conversion +11,036 $0.61 $7K 319,122
2021-02-03 Lucchino David L. President and CEO Sale −5,518 $47.50 $262K 313,604
2021-02-03 Lucchino David L. President and CEO Sale −5,518 $50.00 $276K 308,086
2021-02-03 Lucchino David L. President and CEO Exercise or conversion · Stock Option −11,036 187,995
2021-02-03 Loose Christopher R. Chief Scientific Officer Sale −2,000 $47.19 $94K 21,782
2021-02-02 Lucchino David L. President and CEO Exercise or conversion +5,518 $0.61 $3K 313,604
2021-02-02 Lucchino David L. President and CEO Sale −3,800 $45.76 $174K 309,804
2021-02-02 Lucchino David L. President and CEO Sale −1,709 $46.84 $80K 308,095
2021-02-02 Lucchino David L. President and CEO Sale −9 $47.36 $426 308,086
2021-02-02 Lucchino David L. President and CEO Exercise or conversion · Stock Option −5,518 199,031
2021-02-02 Loose Christopher R. Chief Scientific Officer Sale −8,000 $45.02 $360K 23,782
2021-02-01 Lucchino David L. President and CEO Exercise or conversion +33,102 $0.61 $20K 341,188
2021-02-01 Lucchino David L. President and CEO Sale −2,900 $41.29 $120K 338,288
2021-02-01 Lucchino David L. President and CEO Sale −18,600 $42.85 $797K 319,688

Page 24 of 34 · 670 trades